Peroxide, NO and Iron Signaling in Endothelial Damage

内皮损伤中的过氧化物、NO 和铁信号传导

基本信息

  • 批准号:
    7185810
  • 负责人:
  • 金额:
    $ 28.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-03-17 至 2009-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Long-term goal: The long-term goal of this proposal is to unravel the role of oxidant-induced iron signaling mechanism in endothelial cell apoptosis. Emerging studies indicate that the cellular oxidative damage caused by reactive oxygen and nitrogen species (ROS/RNS) is critically controlled by cellular iron homeostasis. Hypothesis: The general hypotheses to be tested are that (i) peroxide (e.g., H2O2, lipid hydroperoxide)-induced endothelial oxidative damage and apoptosis are mediated by transferrin receptor (TfR)-dependent uptake of transferrin (Tf)-iron and that the TfR is an effective "gatekeeper" and modulator of oxidant-induced apoptosis in endothelial cells, and (ii) nitric oxide (NO) and antioxidants mitigate peroxide-induced endothelial damage by inhibiting iron signaling mechanism. Specific aims: First, we will investigate the effect of extracellular and intracellular hydroperoxides on endothelial iron signaling and apoptosis. Next, we will investigate the effect of cell-permeable esterase-specific NO donors and NO synthase inhibitors on peroxide-induced iron signaling and apoptosis. The objective here will be to establish the link between iron, oxidative/nitrosative stress, and peroxide-induced endothelial toxicity. Finally, we will investigate the effect of antioxidant (enzyme) supplementation on peroxide-induced intracellular oxidative stress, iron signaling, and apoptosis. Methods: We will use the bovine aortic endothelial cells (BAEC) and human aortic endothelial cells (HAEC). The following redox- parameters will be measured: GSH and lipid peroxides; aconitase and iron-regulatory protein activities; TfR expression, 55Fe uptake; caspase signaling, and apoptosis. Superoxide and hydroxyl radicals will be determined by fluorescence and novel spin-trapping (immunoassay) techniques. Significance: Endothelial cell injury is an early oxidative insult in many cardiovascular diseases. Several clinical and basic research studies implicated a role for oxidant-induced iron signaling in vascular oxidative damage. Novelty: This proposal presents a new insight on peroxide-induced iron signaling in endothelial apoptosis and on the role of NO and antioxidants in mitigating these effects.
描述(由申请人提供):长期目标:本提案的长期目标是阐明氧化剂诱导的铁信号传导机制在内皮细胞凋亡中的作用。近年来的研究表明,由活性氧和氮(ROS/RNS)引起的细胞氧化损伤是由细胞内铁稳态控制的。假设:待检验的一般假设为:(i)过氧化物(例如,H2 O2,脂质过氧化氢)诱导的内皮细胞氧化损伤和凋亡介导的转铁蛋白受体(TfR)依赖性摄取转铁蛋白(Tf)-铁和TfR是一个有效的“看门人”和氧化剂诱导的内皮细胞凋亡的调节剂,和(ii)一氧化氮(NO)和抗氧化剂减轻过氧化物诱导的内皮细胞损伤,通过抑制铁信号传导机制。具体目标:首先,我们将研究细胞外和细胞内的氢过氧化物对内皮铁信号和细胞凋亡的影响。接下来,我们将研究细胞渗透性酯酶特异性NO供体和NO合酶抑制剂对过氧化物诱导的铁信号传导和细胞凋亡的影响。本文的目的是建立铁、氧化/亚硝化应激和过氧化物诱导的内皮细胞毒性之间的联系。最后,我们将研究抗氧化剂(酶)补充对过氧化物诱导的细胞内氧化应激,铁信号和细胞凋亡的影响。方法:采用牛主动脉内皮细胞(BAEC)和人主动脉内皮细胞(HAEC)。将测量以下氧化还原参数:GSH和脂质过氧化物;乌头酸酶和铁调节蛋白活性; TfR表达、55 Fe摄取;半胱天冬酶信号传导和细胞凋亡。超氧化物和羟基自由基将通过荧光和新的自旋捕获(免疫测定)技术来确定。 意义:内皮细胞损伤是许多心血管疾病的早期氧化损伤。一些临床和基础研究表明氧化剂诱导的铁信号在血管氧化损伤中的作用。新奇:这一建议提出了一个新的见解过氧化物诱导的铁信号在内皮细胞凋亡和NO和抗氧化剂在减轻这些影响的作用。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BALARAMAN KALYANARAMAN其他文献

BALARAMAN KALYANARAMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BALARAMAN KALYANARAMAN', 18)}}的其他基金

Chemoprevention of lung cancer by targeting lonidamine to mitochondria
通过将氯尼达明靶向线粒体来化学预防肺癌
  • 批准号:
    9763831
  • 财政年份:
    2019
  • 资助金额:
    $ 28.45万
  • 项目类别:
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
通过将氯尼达明靶向线粒体来化学预防肺癌
  • 批准号:
    9915863
  • 财政年份:
    2019
  • 资助金额:
    $ 28.45万
  • 项目类别:
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
通过将氯尼达明靶向线粒体来化学预防肺癌
  • 批准号:
    10489835
  • 财政年份:
    2019
  • 资助金额:
    $ 28.45万
  • 项目类别:
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
通过将氯尼达明靶向线粒体来化学预防肺癌
  • 批准号:
    10687020
  • 财政年份:
    2019
  • 资助金额:
    $ 28.45万
  • 项目类别:
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
通过将氯尼达明靶向线粒体来化学预防肺癌
  • 批准号:
    10476701
  • 财政年份:
    2019
  • 资助金额:
    $ 28.45万
  • 项目类别:
Chemoprevention of Lung Cancer with Mitochondria-Targeted Honokiol
利用线粒体靶向和厚朴酚化学预防肺癌
  • 批准号:
    10497449
  • 财政年份:
    2017
  • 资助金额:
    $ 28.45万
  • 项目类别:
Chemoprevention of lung cancer with mitochondria-targeted honokiol
线粒体靶向和厚朴酚对肺癌的化学预防
  • 批准号:
    10092125
  • 财政年份:
    2017
  • 资助金额:
    $ 28.45万
  • 项目类别:
Mitochondria-targeted Agents in Breast Cancer
乳腺癌中的线粒体靶向药物
  • 批准号:
    8453421
  • 财政年份:
    2010
  • 资助金额:
    $ 28.45万
  • 项目类别:
EPR 2010
EPR 2010
  • 批准号:
    7912542
  • 财政年份:
    2010
  • 资助金额:
    $ 28.45万
  • 项目类别:
Mitochondria-targeted Agents in Breast Cancer
乳腺癌中的线粒体靶向药物
  • 批准号:
    8271285
  • 财政年份:
    2010
  • 资助金额:
    $ 28.45万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了